forum

LALPATHLAB Share Price Discussion

Dr. Lal Pathlabs Ltd.
Sector: Pharmaceuticals and health care
... Read more
LALPATHLAB Share Price *
1,239 -2 (-0.16%)
* (quote may be delayed)

LALPATHLAB Discussion Forum


LALPATHLAB - 347950

Like
reply
Reply
share
Share
ICICI Prudential, D-Mart among Top 5 stocks that can give 10-16% return; here’s why
If the Nifty slips below 10,746, the next support is placed at 10,636. A break below 10,636 will signal a continuation of the decline and may take the index towards 10,450 levels.
Moneycontrol
Like
reply
Reply
share
Share
'Equity market selloff has boosted demand for Gold and Silver'
The overall demand for Gold and silver investments have also increased in the current period to an all-time high, due to volatile Indian equity markets and further concerns about the health of the Indian economy.
Moneycontrol
Like
reply
Reply
share
Share
30 stocks hit 52-week high; is TINA factor driving these shares?
Stocks which bucked the trend include names like Abbott India, Bata India, HDFC AMC, ICICI Lombard, InterGlobe Aviation, Infosys, Petronet LNG, TCS etc. among others.
Moneycontrol
Like
reply
Reply
share
Share
Infosys, HUL among top Nifty stocks that are in buy zone; here’s why
Confirmation of the breakdown will come once the index starts to trade below 10,782. A break below 10,782 would take the Nifty towards the next support which is placed at 10,580 levels
Moneycontrol
Like
reply
Reply
share
Share
Accumulate Dr. Lal PathLabs; target of Rs 1120: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Dr. Lal PathLabs with a target price of Rs 1120 in its research report dated August 14, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

LALPATHLAB NSE CASH LOOKING GOOD TO BUY ABOVE 985, FOR TARGET 995
Like
reply
Reply (4)
share
Share
Latest replies
Mak Mak @makmak
May 9 5:28 PM

Stop loss ?

990 LALPATHLAB 🔥🔥🔥

991.5 🔥🔥🔥
it's called catching at bottom 💪💪💪

992.35 👍👍👍
Like
reply
Reply
share
Share

Dr Lalpath Lab reported lower than Bloomberg expected Q3 results. Company reported Q3 net profit Rs443mn (up 27% YoY) - Bloomberg expectation Rs486mn, other income Rs150mn vs Rs53mn, EBITDA Rs656mn (up 15.6% YoY), EBITDA margin up 88bps at 22.4% and income Rs2.93bn (up 11.3% Yo...
Read more...
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • LALPATHLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization8,783.99
    Enterprise Value8,305.89
    Price to Earnings43.63
    Price to Book Value9.44
    Return on Capital Employed0.33
    Return on Equity0.21
    Face Value10
    Dividend Yield0.01
  • LALPATHLAB Share Price - Technicals

    keyboard_arrow_down
    LALPATHLAB - 52 Week High₹1,360.05
    LALPATHLAB - 52 Week Low₹813.45
  • LALPATHLAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    23-Aug-19Karvy Stock BrokingHold1,285
    14-Aug-19Prabhudas LilladherAccumulate1,120
    20-May-19Prabhudas LilladherAccumulate1,120
    12-Feb-19Prabhudas LilladherAccumulate1,070
    7-Nov-18Prabhudas LilladherAccumulate1,009
    View all LALPATHLAB - Share Targets - Broker Reports
  • LALPATHLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 171309.71312.812301241
    Sep 161318.45132912851292.65
    Sep 1313251360.0513041324.45
    Sep 121337.81339.151301.351309.2
    Sep 111295134412951323.8
  • LALPATHLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,229.44
    30 Day Moving Average₹1,184.27
    50 Day Moving Average₹1,148.37
    100 Day Moving Average₹1,104.72
    200 Day Moving Average₹1,054.51
  • LALPATHLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,024881.870.16
    Operating Profit256229.090.12
    Profit Before Tax255222.90.14
    Net Income167147.210.13
  • LALPATHLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds9317790.2
    Total Liabilities1361210.12
    Total Assets1,0669000.18
  • LALPATHLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity1891670.13
    Cash from Investing Activity-165-137.650.2
    Cash from Financing Activity12-33.78-1.36
    Net Cash Flow36-4.43-9.13
  • LALPATHLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.190.2
    Return on Equity0.210.24
    Return on Capital Employed0.330.36
  • LALPATHLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.61
    3 Year CAGR Growth in Operating Profit0.7
    3 Year CAGR Growth in EBIDTA0.74
    3 Year CAGR Growth in Net Income0.9
    3 Yr CAGR Growth - Diluted EPS0.25
  • LALPATHLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.43
    5 Year CAGR Growth in Operating Profit1.96
    5 Year CAGR Growth in EBIDTA2.19
    5 Year CAGR Growth in Net Income2.42
    3 Yr CAGR Growth - Diluted EPS-0.79
  • LALPATHLAB Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 5 4:23 PM
    ICICI Prudential, D-Mart among Top 5 stocks that can give 10-16% return; here’s why
    Moneycontrol
    NewsBot
    Sep 4 4:48 PM
    'Equity market selloff has boosted demand for Gold and Silver'
    Moneycontrol
    NewsBot
    Sep 4 3:38 PM
    30 stocks hit 52-week high; is TINA factor driving these shares?
    Moneycontrol
    NewsBot
    Aug 22 6:13 PM
    Infosys, HUL among top Nifty stocks that are in buy zone; here’s why
    Moneycontrol
    NewsBot
    Aug 14 10:08 PM
    Accumulate Dr. Lal PathLabs; target of Rs 1120: Prabhudas Lilladher
    moneycontrol.com
    NewsBot
    Jul 15 8:38 PM
    NewsBot
    Jul 15 7:38 PM
    NewsBot
    Jul 12 10:23 PM
    NewsBot
    May 17 9:43 PM
    NewsBot
    Apr 17 8:43 PM
  • LALPATHLAB - Related Communities

    keyboard_arrow_down
    Sakar Healthcare Ltd. Sector: Pharmac...
    Metropolis Healthcare Ltd. Sector: Ph...
    Vimta Labs Ltd. Sector: Pharmaceutica...
    Thyrocare Technologies Ltd. Sector: P...
    Shalby Ltd. Sector: Pharmaceuticals a...
    Narayana Hrudayalaya Ltd. Sector: Pha...
    Lotus Eye Hospital and Institute Ltd....
    Dr. Lal Pathlabs Ltd. Sector: Pharmac...
    Indraprastha Medical Corporation Ltd....
    Healthcare Global Enterprises Ltd. Se...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.